Hearing Loss Trial, Recruiting NCT06465979 Sponsor: Marquette University Condition: Hearing Loss
Back to Hearing Loss

Hearing Loss Trial, Recruiting

NCT06465979
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are able to understand and recognise spoken words in English
  • People who speak North American English fluently
  • Adults between the ages of 18 and 65 years old
  • People whose hearing test results fall within one of these ranges: mild hearing loss (up to 25 decibels of hearing loss), moderate hearing loss (up to 40 decibels of hearing loss), or moderately severe hearing loss (up to 55 decibels of hearing loss) across a range of sound frequencies — or people who use a cochlear implant
  • People who do not have any language-learning difficulties or other cognitive (thinking and processing) disabilities

Who may not be able to join:

  • People who are unable to recognise spoken words in English
  • People who are not fluent speakers of North American English
  • People under the age of 18
  • People over the age of 65
  • People whose hearing test results show hearing loss greater than the levels described above across the relevant sound frequencies (confirm with trial site for exact thresholds that apply to each category)
  • People who have language-learning difficulties or other cognitive disabilities

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Christian Stilp, PhD, Marquette University

Phone: 4142881455

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Marquette University
Registry
ClinicalTrials.gov
Start date
19 September 2023
Est. completion
30 June 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Speech categorization

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov